Dr. Martin Fensch: Championing Pharmaceutical Innovation in Germany
Dr. Martin Fensch leads Governmental Affairs at Daiichi Sankyo, focusing on innovative Oncology and Cardiovascular treatments. With 18 years in pharma and a journalism background, he champions teamwork and diversity while advocating for health policies that promote innovation in Germany.
Dr. Martin Fensch currently holds the position of Vice President for Governmental Affairs and Strategic Partnerships at Daiichi Sankyo Europe GmbH, a leading pharmaceutical company based in Japan. His role involves advocating for innovative treatments in Oncology and Cardiovascular diseases. Dr. Fensch brings over 18 years of expertise in the pharmaceutical sector, with a strong focus on team development and external collaborations, fostering a diverse and trusting work environment. Before joining Daiichi Sankyo in 2022, he had a decade-long tenure as Managing Director at Pfizer in Germany, where he influenced policies and communications. Sporting a journalism background and a doctorate in philosophy, Dr. Fensch also authored the book “News and Fake News on Vaccination” in 2022 and teaches Public Relations at ESCP Business School. Additionally, he actively contributes to several health-focused organizations and supports youth mentorship programs.
The health sector in Germany is evolving, and there is ongoing discussion regarding its role as a focal point for pharmaceutical innovation in Europe. Dr. Fensch’s insights reflect the growing integration of governmental affairs in shaping healthcare policies and creating a more conducive environment for pharmaceutical advancements. His dual experience in policy advocacy and corporate leadership underlines the importance of strategic partnerships in addressing healthcare challenges, particularly in the fields of Oncology and Cardiovascular medicine.
In conclusion, Dr. Fensch’s extensive experience and proactive approach exemplify the potential for Germany to re-emerge as a pivotal player in the European pharmaceutical landscape. His efforts to advance innovation through collaboration and supportive policies are crucial for fostering a thriving health sector.
Original Source: live.handelsblatt.com